APA-čujuhus (7. p.)

Sive, J., Buck, G., Fielding, A., Lazarus, H., Litzow, M., Luger, S., . . . Goldstone, A. (2010). Inability to Tolerate Standard Therapy Is a Major Reason for Poor Outcome In Older Adults with Acute Lymphoblastic Leukemia (ALL) Results From the International MRC/ECOG Trial.

Chicago-čujuhus (17. p.)

Sive, J., et al. Inability to Tolerate Standard Therapy Is a Major Reason for Poor Outcome In Older Adults with Acute Lymphoblastic Leukemia (ALL) Results From the International MRC/ECOG Trial. 2010.

MLA-čujuhus (9. p.)

Sive, J., et al. Inability to Tolerate Standard Therapy Is a Major Reason for Poor Outcome In Older Adults with Acute Lymphoblastic Leukemia (ALL) Results From the International MRC/ECOG Trial. 2010.

Muitte dárkkistit čujuhemiid riektatvuođa, ovdal go geavahat daid iežat deavsttas.